| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |